Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bruce Greenberg Insider Profile
4 Followers
Bruce Greenberg, Interim CFO at Aldeyra Therapeutics, holds 120.70K shares in Aldeyra Therapeutics (Ticker: ALDX). Most recently, Bruce Greenberg Sold $13,201 shares of Aldeyra Therapeutics on Mar 12, 2024 for an estimated value of 44.88K.
Bruce Greenberg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bruce Greenberg's holdings
Insider Roles
Interim CFO
Roles that Bruce Greenberg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bruce Greenberg
Bruce Greenberg's Trading History
List of latest transactions for each holding click on a transaction to see Bruce Greenberg's performance on stock
You May Also Like
Bruce Greenberg insider profile FAQ
What is the percentage of profitable transactions made by Bruce Greenberg?
The percentage of profitable transactions made by Bruce Greenberg is ―.
What is the average return per transaction made by Bruce Greenberg?
The average return per transaction made by Bruce Greenberg is ―.
What stocks does Bruce Greenberg hold?
Bruce Greenberg holds: ALDX stocks.
What was Bruce Greenberg’s latest transaction?
Bruce Greenberg latest transaction was an Informative Sell of $44.88K.
What was Bruce Greenberg's most profitable transaction?
Bruce Greenberg’s most profitable transaction was an Informative Sell of ALDX stock on March 12, 2024. The return on the trade was -30.70%.
What is Bruce Greenberg's role in Aldeyra Therapeutics?
Bruce Greenberg's role in Aldeyra Therapeutics is Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.